A new study published in the British Journal of Radiology highlights that non-contrast abbreviated MRI (NC-AMRI) effectively detects hepatocellular carcinoma (HCC) in high-risk patients. This method offers accuracy comparable to traditional contrast-enhanced MRI but is faster and more cost-effective.
Study Insights
The research, titled “Non-contrast abbreviated MRI for the detection of hepatocellular carcinoma in patients with Liver Imaging Reporting and Data System LR-3 and LR-4 observations in MRI,” involved 63 cirrhotic patients. NC-AMRI demonstrated a sensitivity of 91.7% and specificity of 91.6%, making it a reliable option for early liver cancer detection.
Significance
This method addresses the limitations of ultrasound, especially in patients with higher body weight, by providing a non-invasive and efficient alternative for cancer screening.
Title of Original Paper:
Seven years of Non-invasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features (NIFTP): Rate of Acceptance and Variation of Diagnostic Approaches Across Different Continents
Journal:
The Journal of Clinical Endocrinology & Metabolism
DOI link:
Correspondence:
Yuri Nikiforov, MD, PhD, at the Department of Pathology, University of Pittsburgh
Program:
Doctor of Philosophy Program in Medical Sciences (International)
Advisor:
Prof. Somboon Keelawat, MD.